Skip to main content
Log in

Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

For 2 weeks 27 patients with hypercalcemia received a standard oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) as the sole agent. Results were grouped according to causes of hypercalcemia and compared with effects of APD in 13 normocalcemic patients with Paget's disease of bone and 7 with osteoporosis. In 12 hypercalcemic patients with osteolytic bone lesions and in the 20 normocalcemic patients, the mean serum calcium decreased to final levels that were subnormal and significantly lower than those obtained after treatment of 8 patients with primary hyperparathyroidism. In 3 patients with myeloma and in 4 tumor patients without bone lesions, serum calcium did not always decrease to the normal range. Implications of these observations for the mechanism of hypercalcemia are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nordin BEC (1976) Plasma calcium and plasma magnesium homeostasis. In Nordin BEC (ed): Calcium, Phosphate and Magnesium Metabolism. Churchill Livingstone, Edinburgh, pp 186–216

    Google Scholar 

  2. Parfitt AM (1979) Equilibrium and disequilibrium hypercalcemia. New light on an old concept. Metab Bone Dis Rel Res 1:270–293

    Article  Google Scholar 

  3. Bijvoet OLM, Hosking DJ, Lemkes HHPJ, Reitsma PH, Frijlink WB (1977) Development in the treatment of Paget's disease. In Talmage RV (ed): Endocrinology of Calcium Metabolism. Elsevier/Excerpta Medica, Amsterdam, pp 48–54

    Google Scholar 

  4. Frijlink WB, Bijvoet OLM, Te Velde J, Heynen G (1979) Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1:799–803

    Article  CAS  PubMed  Google Scholar 

  5. Adami S, Frijlink WB, Bijvoet OLM, O'Riordan JLH, Clemens T, Papapoulos SE (1982) Regulation of calcium absorption by 1,25,dihydroxy-vitamin D—studies of the effects of a bisphosphonate treatment. Calcif Tissue Int 34:317–320

    CAS  PubMed  Google Scholar 

  6. Breukelen FJM van, Bijvoet OLM, Oosterom AT van (1979) Inhibition of osteolytic bone lesions by (3-amino-1-hydroxy-propylidene)-1,1-bisphosphonate (APD). Lancet 1:803–805

    Article  PubMed  Google Scholar 

  7. Reitsma PH, Bijvoet OLM, Frijlink WB, Vismans FJFE, Breukelen FJM van (1979) Pharmacology of disodium (3-amino-1-hydroxy-propylidene)-1,1-bisphosphonate. Adv Exp Med Biol 128:219–237

    Google Scholar 

  8. Meunier PJ, Chapuy MC, Alexandre C, Bressot C, Edouard C, Vignon E, Mathieu L, Trechsel U (1979) Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone. Lancet 2:489–492

    Article  CAS  PubMed  Google Scholar 

  9. Siris ES, Sherman WH, Baguiran DC, Schlatterer JP, Osserman EF, Canfield ER (1980) Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma. N Engl J Med 302:310–315

    Article  CAS  PubMed  Google Scholar 

  10. Douglas DL, Duckworth T, Russel RCG, Kanis JA, Preston DJ, Preston FE, Prenton MA, Woodhead JD (1980) Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease. Lancet 1:1043–1047

    Article  CAS  PubMed  Google Scholar 

  11. Reitsma PH, Bijvoet OLM, Verlinden-Ooms H (1980) Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats. Calcif Tissue Int 32:145–157

    CAS  PubMed  Google Scholar 

  12. Lemkes HHPJ, Reitsma PH, Frijlink WB, Verlinden J, Bijvoet OLM (1977) A new diphosphonate: dissociation between effects on cells and mineral in rats and a preliminary trial in Paget's disease. In Massry RG, Ritz E, Rapado A (eds): Homeostasis of Phosphate and Other Minerals. New York, pp 459–469

  13. Prockop DJ, Udenfriend S (1960) A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem 1:228–239

    Article  CAS  PubMed  Google Scholar 

  14. Marshall JH (1969) Measurement and models of skeletal metabolism. In Comar CL, Bronner F (eds): Mineral Metabolism, Vol III, Calcium Physiology. Academic Press, New York, pp 1–122

    Google Scholar 

  15. Bijvoet OLM (1977) Kidney function in calcium and phosphate metabolism. In Avioli LV, Krane SM (eds): Metabolic Bone Disease. Academic Press, New York, pp 49–140

    Google Scholar 

  16. Talmage RV, Kraintz FW, Buchanan D (1955) Effect of parathyroid extract and phosphate salts on renal calcium and phosphate excretion after parathyroidectomy. Proc Soc Exp Biol Med 88:600–604

    CAS  PubMed  Google Scholar 

  17. Talmage RV (1956) Studies on maintenance of serum calcium levels by parathyroid action on bone and kidney. Ann NY Acad Sci 64:326–335

    CAS  Google Scholar 

  18. Massry SC, Friedler RM, Coburn JW (1973) Excretion of phosphate and calcium. Arch Intern Med 131:828–859

    Article  CAS  PubMed  Google Scholar 

  19. Walser M (1969) Renal excretion of alkaline earths. Mineral Metab 3:235–320, 1969

    Google Scholar 

  20. Froeling PGAM, Bijvoet OLM (1974) Kidney-mediated effects of parathyroid hormone on extracellular homeostasis of calcium, phosphate and acid base balance in man. Neth J Med 17:174–183

    CAS  PubMed  Google Scholar 

  21. Eisenberg E (1965) Effects of serum calcium level and parathyroid extract on phosphate and calcium excretion in hypoparathyroid patients. J Clin Invest 44:942–946

    Article  CAS  PubMed  Google Scholar 

  22. Russell RGG, Fleisch H (1976) Pyrophosphate and diphosphonates. In Bourne GH (ed): The Biochemistry and Physiology of Bone, Vol IV. Academic Press, New York, pp. 61–104

    Google Scholar 

  23. Bijvoet OLM, Frijlink WB, Jie K, van der Linden H, Meyer CJLM, Mulder H, van Passen HC, Reitsma PH, te Velde J, de Vries E, van der Wey JP (1980) APD in Paget's disease. Role of the mononuclear-phagocytic system? Arthritis Rheum 23:1193–1204

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Breukelen, F.J.M., Bijvoet, O.L.M., Frijlink, W.B. et al. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium. Calcif Tissue Int 34, 321–327 (1982). https://doi.org/10.1007/BF02411261

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02411261

Key words

Navigation